語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Chronic lymphocytic leukemia
~
Hallek, Michael.
Chronic lymphocytic leukemia
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Chronic lymphocytic leukemia/ edited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky.
其他作者:
Hallek, Michael.
出版者:
Cham :Springer International Publishing : : 2019.,
面頁冊數:
vi, 179 p. :ill., digital ; : 24 cm.;
Contained By:
Springer eBooks
標題:
Chronic lymphocytic leukemia. -
電子資源:
https://doi.org/10.1007/978-3-030-11392-6
ISBN:
9783030113926
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
[electronic resource] /edited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky. - Cham :Springer International Publishing :2019. - vi, 179 p. :ill., digital ;24 cm. - Hematologic malignancies,2197-9766. - Hematologic malignancies..
Pathophysiolgoy -- Diagnostics -- Clinical Presentation -- Prognostic Markers -- Treatment -- Follow-up and Complications -- Related Entities.
This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed.
ISBN: 9783030113926
Standard No.: 10.1007/978-3-030-11392-6doiSubjects--Topical Terms:
778374
Chronic lymphocytic leukemia.
LC Class. No.: RC643 / .C47 2019
Dewey Class. No.: 616.99419
Chronic lymphocytic leukemia
LDR
:02287nam a2200337 a 4500
001
939821
003
DE-He213
005
20190424194549.0
006
m d
007
cr nn 008maaau
008
200414s2019 gw s 0 eng d
020
$a
9783030113926
$q
(electronic bk.)
020
$a
9783030113919
$q
(paper)
024
7
$a
10.1007/978-3-030-11392-6
$2
doi
035
$a
978-3-030-11392-6
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC643
$b
.C47 2019
072
7
$a
MJF
$2
bicssc
072
7
$a
MED038000
$2
bisacsh
072
7
$a
MJF
$2
thema
082
0 4
$a
616.99419
$2
23
090
$a
RC643
$b
.C557 2019
245
0 0
$a
Chronic lymphocytic leukemia
$h
[electronic resource] /
$c
edited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky.
260
$a
Cham :
$c
2019.
$b
Springer International Publishing :
$b
Imprint: Springer,
300
$a
vi, 179 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Hematologic malignancies,
$x
2197-9766
505
0
$a
Pathophysiolgoy -- Diagnostics -- Clinical Presentation -- Prognostic Markers -- Treatment -- Follow-up and Complications -- Related Entities.
520
$a
This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed.
650
0
$a
Chronic lymphocytic leukemia.
$3
778374
650
1 4
$a
Hematology.
$3
645254
650
2 4
$a
Oncology.
$3
593951
700
1
$a
Hallek, Michael.
$3
1226223
700
1
$a
Eichhorst, Barbara.
$3
1226224
700
1
$a
Catovsky, Daniel.
$3
1226225
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer eBooks
830
0
$a
Hematologic malignancies.
$3
890317
856
4 0
$u
https://doi.org/10.1007/978-3-030-11392-6
950
$a
Medicine (Springer-11650)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入